NCT03721549View on ClinicalTrials.gov

Evaluation of Infectivity and Illness of Norwalk GI.1 Virus Lot 001-09NV in the Human Challenge Model

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 3, 2018

Primary Completion Date

November 28, 2018

Study Completion Date

November 28, 2018

Conditions
Norovirus Infection
Interventions
BIOLOGICAL

Norwalk GI.1 Virus

Norwalk virus causes viral gastroenteritis, which is also known as acute nonbacterial gastroenteritis, food poisoning, food infection, or stomach flu.

Trial Locations (1)

92626

WCCT Global, Costa Mesa

Sponsors

Lead Sponsor

WCCT Global

Collaborators (1)

Vaxart
All Listed Sponsors
collaborator

Vaxart

INDUSTRY

lead

WCCT Global

INDUSTRY

NCT03721549 - Evaluation of Infectivity and Illness of Norwalk GI.1 Virus Lot 001-09NV in the Human Challenge Model | Biotech Hunter | Biotech Hunter